164 related articles for article (PubMed ID: 15888029)
41. Pirfenidone inhibits macrophage infiltration in 5/6 nephrectomized rats.
Chen JF; Ni HF; Pan MM; Liu H; Xu M; Zhang MH; Liu BC
Am J Physiol Renal Physiol; 2013 Mar; 304(6):F676-85. PubMed ID: 23152296
[TBL] [Abstract][Full Text] [Related]
42. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
43. Pirfenidone protects against paraquat-induced lung injury and fibrosis in mice by modulation of inflammation, oxidative stress, and gene expression.
Pourgholamhossein F; Rasooli R; Pournamdari M; Pourgholi L; Samareh-Fekri M; Ghazi-Khansari M; Iranpour M; Poursalehi HR; Heidari MR; Mandegary A
Food Chem Toxicol; 2018 Feb; 112():39-46. PubMed ID: 29273418
[TBL] [Abstract][Full Text] [Related]
44. [Effects of diterpene phenol extract of Rosmarinus officinalis on TGFbeta1 and mRNA expressions of its signaling pathway molecules in the lung tissue of pulmonary fibrosis rats].
Yang LT; Liu X; Cheng DY; Fang X; Mu M; Hu XB; Nie L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):819-24. PubMed ID: 23980366
[TBL] [Abstract][Full Text] [Related]
45. Sepiapterin decreases acute rejection and apoptosis in cardiac transplants independently of changes in nitric oxide and inducible nitric-oxide synthase dimerization.
Pieper GM; Ionova IA; Cooley BC; Migrino RQ; Khanna AK; Whitsett J; Vásquez-Vivar J
J Pharmacol Exp Ther; 2009 Jun; 329(3):890-9. PubMed ID: 19307452
[TBL] [Abstract][Full Text] [Related]
46. Transforming growth factor-beta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity.
Boutard V; Havouis R; Fouqueray B; Philippe C; Moulinoux JP; Baud L
J Immunol; 1995 Aug; 155(4):2077-84. PubMed ID: 7636258
[TBL] [Abstract][Full Text] [Related]
47. Arginase inhibition prevents bleomycin-induced pulmonary hypertension, vascular remodeling, and collagen deposition in neonatal rat lungs.
Grasemann H; Dhaliwal R; Ivanovska J; Kantores C; McNamara PJ; Scott JA; Belik J; Jankov RP
Am J Physiol Lung Cell Mol Physiol; 2015 Mar; 308(6):L503-10. PubMed ID: 25595650
[TBL] [Abstract][Full Text] [Related]
48. Sunitinib displays pulmonary fibrosis in experimental rats: Role of IL-17A dependent pathway.
Asker ME; Abdelmeged AA; Shaheen MA; Eissa RG
Int Immunopharmacol; 2023 Jun; 119():110173. PubMed ID: 37058748
[TBL] [Abstract][Full Text] [Related]
49. Decreased Fibrogenesis After Treatment with Pirfenidone in a Newly Developed Mouse Model of Intestinal Fibrosis.
Meier R; Lutz C; Cosín-Roger J; Fagagnini S; Bollmann G; Hünerwadel A; Mamie C; Lang S; Tchouboukov A; Weber FE; Weber A; Rogler G; Hausmann M
Inflamm Bowel Dis; 2016 Mar; 22(3):569-82. PubMed ID: 26848518
[TBL] [Abstract][Full Text] [Related]
50. Design, synthesis, and evaluation of pirfenidone-NSAIDs conjugates for the treatment of idiopathic pulmonary fibrosis.
Lu X; Zhu C; Gao Y; Yu Z; Yan Q; Liu Y; Luo M; Shi X
Bioorg Chem; 2024 Feb; 143():107018. PubMed ID: 38071874
[TBL] [Abstract][Full Text] [Related]
51. Cinnamic acid mitigates methotrexate-induced lung fibrosis in rats: comparative study with pirfenidone.
Abdalhameid E; Abd El-Haleim EA; Abdelsalam RM; Georgy GS; Fawzy HM; Kenawy SA
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):1071-1079. PubMed ID: 37581637
[TBL] [Abstract][Full Text] [Related]
52. Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-β1 and iNOS.
Gungor H; Ekici M; Onder Karayigit M; Turgut NH; Kara H; Arslanbas E
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1659-1670. PubMed ID: 32377772
[TBL] [Abstract][Full Text] [Related]
53. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages.
Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C
Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993
[TBL] [Abstract][Full Text] [Related]
54. Antifibrotic Agent Pirfenidone Protects against Development of Radiation-Induced Pulmonary Fibrosis in a Murine Model.
Qin W; Liu B; Yi M; Li L; Tang Y; Wu B; Yuan X
Radiat Res; 2018 Oct; 190(4):396-403. PubMed ID: 30016220
[TBL] [Abstract][Full Text] [Related]
55. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism.
Hesse M; Modolell M; La Flamme AC; Schito M; Fuentes JM; Cheever AW; Pearce EJ; Wynn TA
J Immunol; 2001 Dec; 167(11):6533-44. PubMed ID: 11714822
[TBL] [Abstract][Full Text] [Related]
56. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
[TBL] [Abstract][Full Text] [Related]
57. Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models.
Yu W; Guo F; Song X
Pharm Biol; 2017 Dec; 55(1):450-455. PubMed ID: 27937011
[TBL] [Abstract][Full Text] [Related]
58. Arginine metabolism in experimental glomerulonephritis: interaction between nitric oxide synthase and arginase.
Cook HT; Jansen A; Lewis S; Largen P; O'Donnell M; Reaveley D; Cattell V
Am J Physiol; 1994 Oct; 267(4 Pt 2):F646-53. PubMed ID: 7524362
[TBL] [Abstract][Full Text] [Related]
59. alpha-Melanocyte-stimulating hormone protects the allograft in experimental heart transplantation.
Gatti S; Colombo G; Buffa R; Turcatti F; Garofalo L; Carboni N; Ferla L; Fassati LR; Lipton JM; Catania A
Transplantation; 2002 Dec; 74(12):1678-84. PubMed ID: 12499879
[TBL] [Abstract][Full Text] [Related]
60. The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen alpha1(I), TIMP-1 and MMP-2.
Di Sario A; Bendia E; Macarri G; Candelaresi C; Taffetani S; Marzioni M; Omenetti A; De Minicis S; Trozzi L; Benedetti A
Dig Liver Dis; 2004 Nov; 36(11):744-51. PubMed ID: 15571005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
